logo
ProjectUnder Regulatory Review

Alembic Pharma Panelav API Manufacturing Facility

Under regulatory review · Gujarat · Last reported May 2025

Source: Samco

Alembic Pharma's API-I & II manufacturing facility at Panelav, Gujarat underwent a routine USFDA inspection focused on current Good Manufacturing Practices (cGMP). The inspection resulted in four observations issued via Form 483, all of which the company considers addressable. Alembic Pharma plans to respond to the USFDA within the prescribed timeline while continuing its operations and product ap

Status
Prospective
Sector
Manufacturing (Industrial)
Location
Panelav, Gujarat, India
Updated
22 Jul 2026
Source
Samco

ConstructChat

Ask ConstructChat about Alembic Pharma Panelav API Manufacturing Facility

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Alembic Pharma Panelav API Manufacturing Facility” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Panelav, Gujarat, India. Taiyo aggregates data on it from Samco.

Participants

Not available for this record.

Status

Original status

under regulatory review

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Alembic Pharma's API-I & II manufacturing facility at Panelav, Gujarat underwent a routine USFDA inspection focused on current Good Manufacturing Practices (cGMP). The inspection resulted in four observations issued via Form 483, all of which the company considers addressable. Alembic Pharma plans to respond to the USFDA within the prescribed timeline while continuing its operations and product approvals.

Original sector

Pharmaceutical Manufacturing

Location

Country

India

State

Gujarat

City

Panelav

Source

Source

Samco

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial)

Article published date

2025-06-04

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project